Specialty Rx Preferred, Non-Preferred Tiers Cropping Up In Exchange Plans
This article was originally published in The Pink Sheet Daily
Health plans offered in state-based exchanges for 2015 are beginning to segment specialty drugs into preferred and non-preferred formulary tiers, enabling them to negotiate more aggressively on drug pricing.
You may also be interested in...
If not reversed by the Biden Administration, demo program that puts plans at increased risk in catastrophic phase would also enhance negotiating leverage for drugs in the protected classes.
Tactic aims to allow incoming Administration to scrutinize so-called ‘midnight rules’ issued in the final days of the Trump Administration before they take effect. Regulators may also solicit stakeholder comments on delayed rules.
The tactic aims to allow the new Biden administration to scrutinize so-called “midnight rules” issued in the final days of the Trump administration before they take effect. One reg targeted by the freeze is the recent SUNSET rule from the US HHS, which would require the department and its agencies – including the FDA – to review all regulations every 10 years to determine whether they’re still necessary.